Academic Journals Database
Disseminating quality controlled scientific knowledge

The Utilization and Limitation of CD133 Epitopes in Lung Cancer Stem Cells Research

ADD TO MY LIST
 
Author(s): Yin CHEN | Hong ZHONG

Journal: Chinese Journal of Lung Cancer
ISSN 1009-3419

Volume: 14;
Issue: 10;
Start page: 825;
Date: 2011;
Original page

Keywords: Stem cells | Lung neoplasms | CD133

ABSTRACT
Lung cancer is one of the most common tumor, which lacks of effective clinical treatment to lead to desirable prognosis. According to cancer stem cell hypothesis, lung cancer stem cells are considered to be responsible for carcinogenesis, development, metastasis, recurrence, invasion, resistance to chemotherapy and radiotherapy of lung cancer. In recent years, more and more institutes used glycosylated CD133 epitopes to define, isolate, purify lung cancer stem cells. However, along with deeply research, the application of CD133 epitopes in lung cancer stem cell research is questioned. The utilization and limitation of CD133 epitopes in lung cancer stem cells research for the past few years is summaried in this review.
Affiliate Program      Why do you need a reservation system?